Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes

Demosthenes G Katritsis1, George C M Siontis, Adnan Kastrati

  • 1Department of Cardiology, Athens Euroclinic, 9 Athanassiadou Str., Athens, Greece. dkatritsis@euroclinic.gr

European Heart Journal
|August 17, 2010
PubMed

Insights

Early coronary angiography for acute coronary syndromes without ST-segment elevation (NSTE-ACS) reduces recurrent ischemia and hospital stay. This invasive approach is superior to medical management, though optimal timing remains debated.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Acute coronary syndromes without ST-segment elevation (NSTE-ACS) require timely management.
  • While invasive strategies are superior to medical management for NSTE-ACS, the optimal timing for coronary angiography is not definitively established.
  • Early intervention may improve patient outcomes but requires careful consideration of risks and benefits.

Purpose of the Study:

  • To compare the clinical outcomes of early versus delayed coronary angiography in patients with NSTE-ACS.
  • To determine if an early invasive strategy impacts mortality, myocardial infarction, recurrent ischemia, or hospital stay.
  • To synthesize evidence from randomized trials to inform clinical practice guidelines.

Main Methods:

  • A meta-analysis of four randomized trials (ABOARD, ELISA, ISAR-COOL, TIMACS) involving 4013 patients with NSTE-ACS.
  • Data from longer follow-up periods were incorporated.
  • Comparison of early (1.16-14 h) versus delayed (20.8-86 h) coronary angiography strategies.

Main Results:

  • No significant difference in the risk of death or myocardial infarction between early and delayed angiography groups.
  • Early intervention significantly reduced the risk of recurrent ischemia (P=0.02) and hospital stay duration (28% reduction, P<0.001).
  • Trends towards decreased major bleeding and composite major adverse events (death, MI, stroke) were observed with early angiography, though not statistically significant.

Conclusions:

  • Early coronary angiography and potential intervention in NSTE-ACS patients significantly lowers the risk of recurrent ischemia.
  • An early invasive strategy is associated with a shorter hospital stay.
  • While not reaching statistical significance in this meta-analysis, early angiography showed a trend towards reduced major adverse events and bleeding.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...